- In April 2024, Bionano announced a strategic alliance with Hangzhou Diagens Biotechnology Co., Ltd. (Diagens) to develop the first cytogenetic workflow that integrates optical genome mapping (OGM) with AI-driven chromosome karyotype analysis. This collaboration focuses on identifying pathogenic structural variants (SVs) associated with recurrent pregnancy loss, critical genomic variants impacting pregnancy outcomes, and developmental challenges in newborns
- In April 2024, Creative Bioarray launched advanced Karyotyping and Chromosome Analysis Services, aimed at improving animal proliferation and breeding. By identifying genetic abnormalities and variations, the service empowers breeders and researchers to enhance production quality and efficiency
- In March 2023, Thermo Fisher Scientific partnered with Pfizer to expand access to next-generation sequencing (NGS)-based testing for cancer patients in international markets, enhancing localized solutions for oncology care
- In January 2023, Agilent announced its acquisition of Avida Biomed, a company specializing in high-performance NGS target enrichment workflows for cancer research, bolstering its cancer diagnostics portfolio
- In November 2022, Danaher Corporation entered a strategic partnership with Duke University to establish its first Danaher Beacon for Gene Therapy Innovation, focusing on advancing gene therapy research and development
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Kits and Reagents, Instruments, Consumables, and Software and Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Immunohistochemistry, Karyotyping, and Other Techniques), Application (Genetic Disorders, Oncology, Personalized Medicine, and Other Applications), End User (Clinical and Research Laboratories, Hospitals and Pathology Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies, and Others) – Industry Trends and Forecast to 2032
.
The Global Molecular Cytogenetic Systems Market size was valued at USD 2.92 USD Billion in 2024.
The Global Molecular Cytogenetic Systems Market is projected to grow at a CAGR of 9.33% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
